We put creative minds to work.


Inspiring innovative research.


Drugs for better quality of life.

Neurim Pharmaceuticals

Neurim Pharmaceuticals is a neuroscience drug discovery and development company creating drugs for brain restoration & reinforcement, focusing on the central nervous system.

Its first approved drug, Circadin® – prolonged release melatonin for insomnia is commercially available in Europe, Asia-Pacific, Latin America, Africa and the Middle East.

Neurim Pharmaceuticals has a promising pipeline of New Chemical Entities effective in Central Nervous System disorders.
The company focuses on the diseases of aging, such as insomnia and neuro-degenerative diseases, with the goal of improving quality of life.

  • Text size: A A A
  • Circadin
  • Recent news

    • Slenyto is now available in Spain!
    • Neurim Pharmaceuticals is attending World Sleep Congress 2022, March 11-16, Rome, Italy
    • Neurim conducted a survey via Brandman Research, assessing the characteristics of insomnia in children with ASD and the distress it causes to the children and their families
  • Partners